👍 Opgen is an amazing company to work with. They provide exceptional genomics services. The staff is knowledgeable and helpful. I'm super satisfied with the results they delivered. Keep up the good work! 👍
12 Reviews
I had a wonderful experience with opgen.com. Their genomics services were top quality, and they exceeded my expectations. The staff was friendly and professional, and the results were delivered on time.
I had a great experience with Opgen. Their genomics services are reliable and accurate. The team was professional, and they provided prompt support when I had questions. I would definitely use them again.
I've been using Opgen's genomics services for a while now, and I'm impressed by the quality of their work. They always deliver accurate results and have excellent customer support. Highly recommended!
Opgen's genomics services exceeded my expectations. The results were precise, and the customer support was exceptional. I highly recommend Opgen for all your genomics needs.
Opgen is a reliable company for genomics services. The quality of their work is exceptional, and they offer great customer support. I'm really satisfied with their services and would highly recommend them.
😊 Opgen is a fantastic company. Their genomics services are reliable and accurate. The staff is friendly and helpful, and they provided excellent support throughout the process. I'm really happy with the results! 😊
Opgen is an outstanding company. Their products are top-notch and their customer service is excellent. They always go above and beyond to ensure customer satisfaction. I highly recommend Opgen to anyone in need of their services.
❤️ I'm extremely satisfied with the genomics services I received from Opgen. The team was efficient, and the results were accurate. I would highly recommend their services to others. ❤️
Opgen's website is user-friendly and easy to navigate. I appreciate the detailed information they provide about their products and services. The ordering process was smooth, and my questions were promptly answered.
I recently used a genomics service from opgen.com and I was impressed with the quality of their work. The results were accurate and they delivered in a timely manner. I would definitely use them again.
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Opgen
OpGen, along with its subsidiaries, Curetis & Ares Genetics, develops & commercializes molecular microbiology solutions.
OpGen: Revolutionizing Molecular Microbiology Solutions
OpGen is a leading molecular diagnostics company that specializes in developing and commercializing innovative solutions for the detection, diagnosis, and treatment of infectious diseases. The company's mission is to provide accurate, reliable, and cost-effective diagnostic tools that enable healthcare professionals to make informed decisions about patient care.
Founded in 2002, OpGen has since established itself as a pioneer in the field of molecular microbiology. The company's proprietary technology platform combines advanced genomics with bioinformatics to deliver rapid and accurate results for a wide range of infectious diseases.
OpGen's subsidiaries include Curetis AG and Ares Genetics GmbH. Curetis is a leading developer of next-generation sequencing (NGS) technology for the diagnosis of severe infections such as sepsis. Ares Genetics focuses on developing innovative solutions for antibiotic resistance testing using AI-powered bioinformatics.
The company's flagship product is the Acuitas® AMR Gene Panel u5.47, which enables rapid identification of antibiotic-resistant pathogens from clinical samples. This groundbreaking solution helps healthcare providers make informed decisions about appropriate antibiotic therapy while reducing the risk of antimicrobial resistance.
OpGen also offers other products such as Acuitas Lighthouse®, an infection control surveillance system that uses NGS technology to track outbreaks in real-time; QuickFISH®, a rapid diagnostic test for identifying pathogens directly from clinical specimens; and PNA FISH®, an FDA-cleared diagnostic test used to identify bloodstream infections caused by gram-positive bacteria.
In addition to its innovative product portfolio, OpGen has also established partnerships with leading academic institutions and research organizations worldwide. These collaborations have enabled the company to expand its knowledge base and develop new technologies that address unmet needs in molecular microbiology.
One example is OpGen's collaboration with New York University Langone Health (NYULH) on developing a novel NGS-based assay for detecting SARS-CoV-2 virus mutations associated with drug resistance or immune evasion. This partnership aims to improve COVID-19 patient outcomes by providing more accurate information about viral variants that may impact treatment efficacy.
Another notable collaboration is OpGen's partnership with Merck KGaA on developing new antibiotics targeting multidrug-resistant bacteria. This joint effort combines Merck KGaA's expertise in drug discovery with OpGen's advanced genomics capabilities to accelerate the development of novel therapeutics against antibiotic-resistant infections.
Overall, OpGen continues to lead innovation in molecular microbiology solutions through its cutting-edge technologies, strategic partnerships, and commitment to improving patient outcomes worldwide. With its focus on addressing unmet needs in infectious disease diagnostics and treatment, this pioneering company remains at the forefront of revolutionizing healthcare delivery globally.
- Website
- opgen.com
- [email protected]
- Address
- 708 quince orchard road
- Categories
- Biotechnology
